The Emory University School of Medicine Postdoctoral Residency Program in Health Service Psychology is based in the Departments of Psychiatry and Behavioral Sciences, Pediatrics, and the Division of Neurosciences & Rehabilitation Medicine (Division of Neuropsychology and Behavioral Health). The residency program is typically a one-year, full-time experience, with exceptions made for personal reasons (e.g., birth of a child, family leave).
The combined position between Early Intervention and Clinical Assessment and Diagnostics integrates time in two clinics at Marcus Autism Center, a subsidiary of Children’s Healthcare of Atlanta. The Marcus Autism Center Early Intervention Clinic is an...
Help design and conduct research in intracortical brain-machine interfaces, systems neuroscience, artificial intelligence while receiving advanced training from a designated Principal Investigator to enhance professional skills and research independence needed for pursuit of a career. Applies advanced machine learning algorithms to analyze and interpret electrophysiological data from the brain. Develops new ideas that promote current research. Prepares and publishes scientific manuscripts under the direction of the Principal Investigator. May be responsible for operation of specific equipment. Positions are temporary appointments as a research trainee. Postdoctoral fellow is an entry level position in which the research fellow receives training under close...
We are seeking a highly motivated individual for the position of Post Doctoral Fellow in the laboratory of Dr. Bhavya Doshi.
The Doshi Laboratory is interested in processes that drive alloantibody and anti-drug antibody responses in gene and protein-based therapies, with a particular emphasis on hemophilia. The hemophilias are X-linked bleeding disorders resulting from defects in coagulation factor VIII or IX. These disorders manifest as frequent bleeding episodes either spontaneously or in response to minor trauma. These patients are treated with either prophylactic infusions of factor VIII/IX concentrates, or more recently, non-factor therapeutics. The major complication of factor replacement therapy is the development of neutralizing alloantibodies, or inhibitors,...